605116.SH
奥锐特
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 19.48
−2.36%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
11.6x
Market Cap
CNY 7.91B
MomentumView details →
1D Return
−2.36%
YTD Return
−21.60%
RSI (14)
45.8
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
11.6x
Market Cap
CNY 7.91B
RSI (14)
45.8
MomentumView details →
1D Return
−2.36%
YTD Return
−21.60%
Similar companies
Latest newsMore news →
Aoruite announced its first-half 2026 results: net profit attributable to shareholders was 159 million yuan, down 32.42% year-on-year.8d agoAurit's wholly-owned subsidiary Yangzhou Aurit received a drug supplementary application approval notice from China's National Medical Products Administration for a new 1mg specification of estradiol tablets/estradiol-dydrogesterone tablets composite packaging.12d ago